Loading...

AARTIPHARM Aarti Pharmalabs Ltd Investor Conferences Announcement

rt P

RTPH

Aarti Pharmalabs Ltd

(AARTIPHARM)

2025 Announcement

Show Summary

Show Summary

Investor Meet Scheduled

Compliance Report

Earnings Call Transcript

Earnings Call Recording

Financial Results Publication

Q4 FY25 Presentation

Stock Options Granted

Earnings Conference Call

EcoVadis Gold Rating

RTA Contact Update

Sustainability Milestone

Compliance Certificate

Joint Venture Established

Earnings Call Transcript

Earnings Call Recording

Financial Results Publication

Investor Presentation

Earnings Conference Call

Plant Re-Opening

Compliance Certificate

Equity Stake Acquisition

Vapi Plant Closure

New Compliance Officer

Earnings Call Transcript

Financial Results Publication

Earnings Call Recording

Management Change

Q2/H1 FY25 Results

Earnings Call Scheduled

Compliance Certificate

Directorate Change

Investor Presentation

Financial Results Publication

Earnings Announcement

Results Presentation

Earnings Conference Call

Publication Advertisement

AGM Announcement

Clarification on Closure of...

Certificate Submission

Credit Rating Announcement

Manufacturing Plant Closure

Compliance Report Submission

Financial Results Publication

Results Presentation

Appointment of Board Member...

Appointment of Directors an...

Board Meeting Outcome

Stock Option Grant

Earnings Call Scheduled

Certificate Submission

Regulatory Compliance

Compliance Certificate

Publication of Financial Re...

Earnings Conference Call

Results Presentation

Earnings Conference Call

Certificate Submission

Grant of Stock Options

Earnings Call Transcript

Conference Call Recording

Financial Results Publication

Conference Call

Certificate Submission

Investor Presentation

Financial Statements, Earni...

Financial Statements

Financial Statements

Conference Call Recording

Financial Statements

Earnings Releases

Financial Statements

Financial Statements

Analyst Presentation

Merger of Equals

Related Party Transactions ...

Financial Results Publication

Related Party Transactions ...

External Links:

Data:

Aarti Pharmalabs Ltd has published its Investor Presentation for Q3 FY25, detailing its performance, including a revenue of INR 15,112 million for FY23 and a global market share of 15-20% in Xanthine derivatives.

AI Assistant

Aarti Pharmalabs Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.